Health Care Select Sector SPDR Fund (SD7C)
XHAN 
Summary
SD7C Chart
XLV: The Simple Case For Overweighting U.S. Health Care
The H ealth Care Select Sector SPDR is comprised of all the Health Care stocks inside the S&P 500 Index. Its expense ratio is only 0.08% and XLV has $41.2B in AUM. The simple case for overweighting U.S. Health Care is that XLV currently features a unique combination of a low beta, moderate growth, and excellent momentum and sentiment. XLV also offers terrific growth-at-a-reasonable-price features, but only on a forward basis. A GARP analysis based on historical metrics highlights an interesting divide worth watching.
Best-Performing ETFs of November
November muted for markets, but ETFs like SPYM, BWET, WNTR, LITP and OZEM stand out.
XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way
The Fed has begun to reduce interest rates in the U.S. This decision will incentivize the deployment of funding in the healthcare industry. The top holdings of XLV are profitable firms, with a median expected growth rate of 6.53% in their revenues. The U.S. legislation that mandates drugmakers to lower the selling price of their medicine in the country will only be applied to Medicaid beneficiaries, which has a limited effect.
Health Care Select Sector SPDR Fund (SD7C) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Health Care Select Sector SPDR Fund ever had a stock split?
Health Care Select Sector SPDR Fund Profile
| XHAN Exchange | US Country |
Overview
The fund outlined seeks to mirror the performance of a specific index focused on the healthcare sector. It adopts a replication strategy, investing primarily in the stocks that form part of the index it tracks. This approach ensures that the fund's performance closely aligns with that of the index. The covered industries within this index encompass a broad range of companies involved in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology. By focusing on these areas, the fund positions itself within an essential and often rapidly evolving segment of the economy. The fund is characterized by its non-diversified status, meaning it might invest more heavily in specific securities than a diversified fund would, potentially increasing its risk and return profile.
Products and Services
- Pharmaceuticals:
- Health Care Equipment & Supplies:
- Health Care Providers & Services:
- Biotechnology:
- Life Sciences Tools & Services:
- Health Care Technology:
This includes companies involved in the research, development, manufacturing, and marketing of medicines and drugs. Pharmaceuticals are vital for treating and preventing diseases, making this sector a crucial part of the healthcare industry and a significant component of the index the fund tracks.
This category comprises businesses that produce medical equipment, surgical supplies, and healthcare products. These are indispensable tools in diagnostics, treatment, and patient care, contributing to the advancement of the healthcare field and forming another vital segment of the index.
Companies falling into this sector offer medical services directly to patients. This can include hospitals, nursing homes, diagnostics laboratories, and outpatient care centers. Their inclusion in the index indicates the fund's investment in firms directly involved in delivering healthcare services to the public.
This area focuses on companies that utilize biological processes for medical research, development, and production. Biotechnology is at the forefront of developing innovative therapies and drugs, often using living organisms or molecular biology techniques. It plays a significant role in the healthcare sector by contributing to new medical breakthroughs, reflected in the index composition.
It covers enterprises providing products and services essential for scientific research, including the development of drug discovery and diagnostics solutions. This segment supports the healthcare industry's broader ecosystem by enabling the research and development activities fundamental to innovation.
This last sector includes companies that apply technology to enhance healthcare delivery and efficiency. Health care technology innovations range from electronic health records and telemedicine to wearable medical devices and health information systems, signaling the increasing role of technology in improving healthcare outcomes.
Contact Information
